Health News

Scientists from St. Jude Children’s Research Hospital and the Children’s Oncology Group (COG) have discovered in children with acute lymphoblastic leukemia (ALL) scores of inherited genetic variations that clinicians might be able to use as guideposts for designing more effective chemotherapy for this cancer.

Read more

Filed under: Pharmacy News
Tags: cancer, gene, Genetic, leukemia, Oncology, Pharmacy

Related posts

• Research finds more than 100 gene variations linked with response to leukemia treatment (0)
  Scientists from St. Jude Children's Research Hospital and the Children's Oncology Group (COG) have discovered in children with acute lymphoblastic leukemia (ALL) scores of inherited genetic variations that clinicians might be able to use as guideposts for designing more effective chemotherapy for this cancer. Read more [tags] Pharmacy News [/tags]
  
  
• Scientists Rediscover Gene Target For Cancer Therapy (0)
  Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, gained international validation of the cutting-edge science behind its lead oncology product, Rexin-G, when scientists around the world rediscovered the Cyclin G1 gene to be a major locus of cancer pathogenesis and disease progression, and thus a prime target for anti-cancer therapies... Read [...]
  
  
• Vorinostat in addition to chemotherapy drugs improves remission rates in AML patients (0)
  Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center reported at the 53rd Annual Meeting of the American Society of Hematology. Read more [tags] Pharmacy News [/tags]
  
  
• Vaccine improves survival of glioblastoma patients in phase II clinical trial: Researchers (0)
  A vaccine that turns the immune system against brain tumor cells bearing a genetic mutation that drives the most aggressive form of glioblastoma multiforme improved survival of patients in a phase II clinical trial, researchers at Duke University and The University of Texas MD Anderson Cancer Center reported today in the Journal of Clinical Oncology. Read [...]
  
  
• Transgenomic Develops New Assays To Detect EGFR Mutations Using COLD-PCR (0)
  Transgenomic, Inc. (OTC Bulletin Board: TBIO) announced completion of a development study of several new assays to detect genetic mutations using the Company's proprietary Co-amplification at Lower Denaturing Temperature PCR (COLD-PCR) technology in the Epidermal Growth Factor Receptor (EGFR) gene. EGFR mutations are found in a number of cancers, including lung and colorectal cancers... Read more [tags] [...]